Quality of Life Analysis of TORCH, a Randomized Trial Testing First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer
収録刊行物
-
- Journal of Thoracic Oncology
-
Journal of Thoracic Oncology 7 (12), 1830-1844, 2012-12
Elsevier BV